(3-nitrobenzoyl)alanine has been researched along with 1-methyltryptophan in 1 studies
| Studies ((3-nitrobenzoyl)alanine) | Trials ((3-nitrobenzoyl)alanine) | Recent Studies (post-2010) ((3-nitrobenzoyl)alanine) | Studies (1-methyltryptophan) | Trials (1-methyltryptophan) | Recent Studies (post-2010) (1-methyltryptophan) |
|---|---|---|---|---|---|
| 15 | 0 | 3 | 8 | 0 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dounay, AB; Tuttle, JB; Verhoest, PR | 1 |
1 review(s) available for (3-nitrobenzoyl)alanine and 1-methyltryptophan
| Article | Year |
|---|---|
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.
Topics: Animals; Antineoplastic Agents; Central Nervous System Diseases; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Kynurenine 3-Monooxygenase; Signal Transduction; Transaminases | 2015 |